Investor profile
Blue Ox Healthcare Partners
PE
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Blue Ox Healthcare Partners is a private equity firm investing growth capital in commercial-stage healthcare companies. We believe innovation centered on the individual is the key to making healthcare more effective and affordable for everyone. We focus on businesses in three core areas – Precision Health, Healthcare Delivery, and Affordability – driving the transformation towards individuality and value-based care, concentrating on those that incorporate technology to create critical advancements. We believe they represent the most powerful forces improving healthcare and offer the best opportunities for growth investment. Blue Ox has the end to end vision to see what's possible, and the experience and relationships to optimize deployment, reimbursement, and utilization to make it a reality. Since 2017 we have led over $200 million of equity investments, including over $85 million invested and committed directly by Blue Ox.
Notable quotes
“Innovations at the intersection of biology, technology, and data science are allowing new levels of precision in treating the unique health needs of each individual. Collectively, Precision Health innovations are creating a new path to realize the promise of better healthcare accessible to all.”
“Healthcare is moving towards individualised therapies and financing. Companies that create the science and technology innovations must have the resources to grow and the expertise to introduce these disruptive services to a value-based healthcare industry. Epic's revolutionary diagnostics and decision support analytics optimize cancer treatment by ensuring each patient's unique cancer cells get therapy that offers the highest likelihood of prolonged survival while avoiding wasteful treatments that the patient's individual cancer cells do not have the biology to respond to.”
“We have domain expertise in the middle-market and lower middle-market healthcare sector.”
Team
Charles D. Kennedy, MD
Managing Partner & CEO
Oded Levy
Managing Partner & President
John A. Neczesny
Managing Partner & COO
Sheila H. Schweitzer
Co-Founder & Managing Partner
Alex R. Rogers
Principal
Mary G. Chelini
Analyst
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Epic Sciences | Series G | $24m | 2023-04 |
| Epic Sciences | Series F | $43m | 2022-06 |
| Gemelli Biotech | Series A | $19m | 2022-06 |
| Sera Prognostics | Series E | $100m | 2021-04 |
| Sera Prognostics | Series D | $36m | 2019-11 |
| Delphi Behavioral Health Group | Growth | — | 2014 |
| Apollo Medical Holdings | Growth | — | — |
| MedSave USA | Growth | — | — |
| Healarium | Growth | — | — |
| PatientMatters | Growth | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Deerfield Management | 2 |
| Labcorp | 2 |
| Domain Associates | 2 |
| Arsenal Capital Partners | 1 |
| Anthem | 1 |
| Vivo Capital | 1 |
Fit check
Is Blue Ox Healthcare Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit